Medical Device Licences could soon become easier and quicker to obtain in India, a move that may do more than reduce paperwork.
AI could soon become one of the strongest tools to help doctors prevent cervical cancer before it develops.
Aurobindo Pharma's API Plant Clears FDA Review With Minor Findings as the company received only two observations from the US Food and Drug Administration (USFDA) following an inspection of one of its API plant facilities.
.jpg "India May Scrap 60 percent Shelf Life Rule for Imported Drugs")
The Imported Drug Shelf Life Rule could soon see a major change in India. The Central government has proposed scrapping the existing 60 percent residual shelf life requirement for imported medicines and replacing it with a simpler 12-month rule.
The Centre is planning a major regulatory change that could make drug import license procedures easier for pharmaceutical companies involved in early-stage research.
Lupin secures a tentative approval from the USFDA further expanding India as the global leader in the pharmaceutical industry the drug actively blocks testosterone from stimulating cancer cell growth
.jpg "Government Demands 1 year Residual Shell Life for Imported Drugs")
A new rule comes into line for expanding the residual shell life of imported drugs in India,amid the wastage of medicines and the capital loss in operation and supply chain management
Alembic Pharma has gained entry into the USD 27 million US flu drug market after receiving USFDA approval for its generic flu drug, Oseltamivir Phosphate for Oral Suspension.
A packaging loophole allegedly helped counterfeit medicines enter global markets using genuine-looking pharmaceutical packaging.
Air Suvidha 2.0 is now mandatory for all international passengers arriving in India as the government steps up airport health screening amid the ongoing Ebola outbreak in parts of Africa.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")